Shane Matte
BioTuesdays
Recent Quotes
"RP has successfully completed its first-in-human clinical study of the company's autologous cell therapy for the treatment of androgenetic alopecia."
—
Shane Matte, BioTuesdays
(3/14/17)
more >
"The validation program for DXD's Hodgkin's lymphoma test (Telo-HL) is under way."
—
Shane Matte, BioTuesdays
(2/23/17)
more >
Due to permission requirements, not all quotes are shown.
